The multidose vials typically use some sort of preservative.
My guess is that management saw an early fix for this and rather than being shut down by the FDA, voluntarily recalled all the vials and will suggest a compromise with the FDA.
Today is a buying opportunity but MM's will likely push this down further unless another Institutional Buyer moves in.
The algorithmic trading brought waves upon waves of selling pressure. We should bounce within the week.
If I were Amgen, I'd buy out this product right away knowing that a quick fix is very likely!
Similar to the flu vaccine going from multi-vial to single vial. We see it also in the Lidocaine for anesthetics.
Per CC the company will work with the FDA to re-introduce the product. AFFY did NOT try to hide anything, unlike dozens of other companies. Stock overly punished today.
there were risk factors brought up by a partner ( Fresenius Medical) long before this current problem. what do you think of that?
where are you getting is info?